Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1574335

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1574335

Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing)), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User - Global Forecast to 2029

PUBLISHED:
PAGES: 334 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global cattle & porcine/swine reproductive diseases market is projected to reach USD 975.8 million by 2029 from USD 758.2 million in 2024 at a CAGR of 5.2%. Between January 2021 and August 2024, major players in this market adopted various strategies to expand their global presence and increase market share. These tactics include entering into strategic agreements, divestitures, expanding operations, and acquiring other companies. These efforts aim to enhance product portfolios, improve efficiency, and tap into new regional markets. The competitive landscape illustrates the industry's focus on meeting the rising demand for reproductive disease treatments in cattle and pigs, which is crucial for supporting the global livestock sector.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsProduct, Disease, Animal and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The Pharmaceutical segment is expected to grow at the second highest CAGR in the cattle & porcine/swine reproductive diseases market."

By product type, the pharmaceuticals segment represents the second highest CAGR in the cattle & porcine/swine reproductive diseases market. This is mainly due to some crucial factors. Advancements in the manufacturing of vaccines, such as the development of more effective formulations and sustainable production practices, have a great influence on market growth. The demand for the above-mentioned pharmaceutical products has increased due to the growing incidence of reproductive diseases in farm animals. The development of diagnostic tools supplements the application of vaccines and antibiotics, enabling timely and efficient disease detection. These two innovations, along with other improvements in their efficacy, have strongly supported the top market position of the pharmaceuticals segment.

"Bovine Viral Diarrhea (BVD) segment witnessed the second-highest CAGR in the cattle & porcine/swine reproductive diseases market."

BVD is expected to be the second fastest-growing segment in terms of CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors have contributed to this growth: first, BVD affects several million cattle worldwide, resulting in marked economic losses due to reduced milk production and poor meat quality. Further, the various symptoms and complications of the disease necessitate a fitting response on the part of farmers and veterinarians. Increased regulatory focus, besides active initiatives by the industry for control and eradication of BVD, also drives the market. As such efforts start turning more concentrated and fruitful, solutions and services directed at overcoming BVD further amplify the demand for the same, thereby fueling market growth.

"The Porcine segment of the cattle & porcine/swine reproductive diseases market accounted for the second largest market share."

Based on animal type, the porcine segment accounted for the second largest market share in the cattle & porcine/swine reproductive diseases market because of high economic impact of diseases like Porcine Reproductive and Respiratory Syndrome (PRRS) on pig farms drives significant spending on management and prevention. Second, the global rise in pork consumption and intensive pig farming practices increase the risk of disease spread, highlighting the need for effective disease control. Lastly, ongoing research works in vaccine and treatment options for porcine diseases boost market growth by offering better solutions to manage and prevent outbreaks. As pork production continues to expand, the focus on controlling reproductive diseases in pigs remains a high priority, further driving market demand.

"Veterinary hospitals and clinics segment of the cattle & porcine/swine reproductive diseases market is expected to witness the second highest CAGR."

By end user, veterinary hospitals & clinics are expected to record the second-highest CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors contribute to such significant growth. Veterinary hospitals & clinics provide a place of advanced diagnostics and treatments essential for such specialized care, especially in reproductive problems in livestock. Due to this realization, farmers view these facilities as a source of expert medical services, thus making them seek accurate disease detection and a definite treatment plan. Besides this, increasing awareness concerning regular visits to veterinary institutes has also made farmers rely more on such institutions for preventive as well as curative purposes. The quality and customized services offered by veterinary clinics and hospitals contribute considerably to their popularity in the market.

"North America is expected to have the second highest CAGR in the cattle & porcine/swine reproductive diseases market, in the forecast period."

In the North America region, the cattle & porcine/swine reproductive diseases market has grown significantly. The region's extensive cattle and pig farms drive a significant demand for reproductive health products and services. This demand is supported by well-established veterinary research institutions that foster innovation and advancements in disease management. Furthermore, strong government support and funding for animal health initiatives in countries such as the US and Canada enhance the market's robustness. The emphasis on boosting livestock productivity and upholding high standards of animal welfare also strengthens the region's position in the global market.

A breakdown of the primary participants (supply side) for the cattle & porcine/swine reproductive diseases market referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-20%, and Tier 3-35%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-40%, Europe-20%, Asia Pacific-25%, Latin America-10%, and Middle East & Africa-5%

A breakdown of the primary participants (demand side) for the cattle & porcine/swine reproductive diseases market refer to for the report is provided below:

  • By End User Type: Cattle and Porcine Farms-55%, Veterinary Hospitals and Clinics-30%, and Veterinary Reference Laboratory-15%
  • By Designation: Veterinarians-45%, Farm Owners-40%, and Laboratory Technicians-15%
  • By Region: North America-34%, Europe-27%, Asia Pacific-23%, Latin America-9%, and Middle East & Africa-7%

Key Market Players:

The prominent players in the cattle & porcine/swine reproductive diseases market include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany), Virbac (France), Elanco Animal Health Incorporated (US), Vetoquinol S.A. (France), Ceva Sante Animale (France), Idexx Laboratories (US), Thermo Fisher Scientific Inc. (US), Biochek Smart Veterinary Diagnostics (Netherlands), Ring Biotechnology Co Ltd. (China), Sequent Scientific Limited (India), Hipra (Spain), Qiagen N.V. (Germany), Innovative Diagnostics (France), Colorado Serum Company (US), Indian Immunologicals Ltd (US), Refit Animal Care (India), Calier (US), Megacor Diagnostik GmBH (Austria), Vetanco (Brazil), Biogenesis Bago (Argentina), Advacare Pharma (US), Bio-X Diagnostics S.A. (Belgium), Pax Healthcare (India).

Research Coverage:

The market analysis examines the cattle & porcine/swine reproductive diseases market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product type, disease type, animal type, end user type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the cattle & porcine/swine reproductive diseases market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.

This report provides insights into the following pointers:

  • Analysis of key Drivers: Drivers (Rising demand for animal-derived food products, Increasing prevalence of reproductive health issues, Growing number of veterinary practitioner in developed markets, Increasing per capita income of farmers in developing countries), Restrains (Lack of awareness and knowledge among small-scale farmers), Opportunities (Advancements in veterinary healthcare, Untapped emerging markets), Challenges (Stringent regulatory guidelines for livestock industry) influencing the growth of the cattle & porcine/swine reproductive diseases market.
  • Market Penetration: Comprehensive information on the product portfolios of the leading companies in the cattle & porcine/swine reproductive diseases market. The report breaks down the market by product type, disease type, animal type, end user type and region.
  • Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the cattle & porcine/swine reproductive diseases market.
  • Market Development: Comprehensive data on attractive rising markets broken down by product type, disease type, animal type, end user type and region.
  • Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the cattle & porcine/swine reproductive diseases market.
  • Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.
Show more
Product Code: MD 9200

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • 1.2.3 YEARS CONSIDERED
    • 1.2.4 CURRENCY CONSIDERED
  • 1.3 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
    • 2.4.1 STUDY ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET OVERVIEW
  • 4.2 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT AND COUNTRY (2023)
  • 4.3 REGIONAL MIX: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 4.4 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for animal-derived food products
      • 5.2.1.2 Increasing prevalence of reproductive health issues
      • 5.2.1.3 Rising number of veterinary practitioners in developed markets
      • 5.2.1.4 Increasing per capita income of farmers in emerging markets
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited awareness & education among small-scale farmers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in veterinary healthcare
      • 5.2.3.2 High growth potential of emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory guidelines for livestock industry
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 INCREASING ADOPTION OF VACCINATION PROGRAMS
    • 5.3.2 EMPHASIS ON SUSTAINABLE PRACTICES
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Vaccination technologies
      • 5.4.1.2 Diagnostic tools
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Genomic selection & breeding
      • 5.4.2.2 Precision livestock farming
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Nutritional supplements & additives
      • 5.4.3.2 Integration of livestock management software
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT OF NEW ENTRANTS
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF SUBSTITUTES
    • 5.5.5 COMPETITIVE RIVALRY
  • 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.6.2 BUYING CRITERIA
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY ANALYSIS
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT PUBLICATION TRENDS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
    • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR CATTLE & PORCINE REPRODUCTIVE PRODUCTS
  • 5.10 PRICING ANALYSIS
    • 5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
    • 5.10.2 AVERAGE SELLING PRICE TREND OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION
  • 5.11 REIMBURSEMENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS
  • 5.13 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.14 IMPACT OF GEN AI ON CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 INNOVATION IN BOVINE REPRODUCTIVE DISEASE VACCINATION
    • 5.16.2 TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH
    • 5.16.3 INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 VALUE CHAIN ANALYSIS
  • 5.19 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESSES
  • 5.21 INVESTMENT & FUNDING SCENARIO

6 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 DIAGNOSTICS
    • 6.2.1 ELISA TEST KITS
      • 6.2.1.1 Advancements in biotechnology to drive market
    • 6.2.2 PCR TEST KITS
      • 6.2.2.1 Increasing adoption of on-farm PCR testing solutions to fuel uptake
    • 6.2.3 RAPID ANTIGEN TEST KITS
      • 6.2.3.1 Growing demand for reliable solutions with quick turnaround time to drive market
    • 6.2.4 OTHER DIAGNOSTIC PRODUCTS
  • 6.3 PHARMACEUTICALS
    • 6.3.1 VACCINES
      • 6.3.1.1 Enhancements in vaccine technology & formulation to drive market
    • 6.3.2 ANTIBIOTICS
      • 6.3.2.1 Convenient purchase options and long-term benefits to boost demand
    • 6.3.3 HORMONAL THERAPY
      • 6.3.3.1 Ability to mimic natural hormones to boost demand
    • 6.3.4 OTHER PHARMACEUTICAL PRODUCTS
  • 6.4 SUPPLEMENTS
    • 6.4.1 VITAMINS & MINERALS
      • 6.4.1.1 Rising focus on nutrition and reproductive health to support market growth
    • 6.4.2 OTHER SUPPLEMENTS

7 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE

  • 7.1 INTRODUCTION
  • 7.2 LEPTOSPIROSIS
    • 7.2.1 RISING CASES DUE TO CLIMATE CHANGE TO DRIVE MARKET
  • 7.3 BRUCELLOSIS
    • 7.3.1 IMPACT ON LIVESTOCK PRODUCTIVITY DUE TO CONTAGIOUS NATURE TO SUPPORT MARKET GROWTH
  • 7.4 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS)
    • 7.4.1 INCREASING PORK CONSUMPTION TO PROPEL MARKET
  • 7.5 BOVINE VIRAL DIARRHEA (BVD)
    • 7.5.1 HIGH MORBIDITY RATE TO DRIVE MARKET
  • 7.6 VIBRIOSIS
    • 7.6.1 GROWING DEMAND FOR HIGH-YIELDING LIVESTOCK TO SUPPORT MARKET GROWTH
  • 7.7 OTHER CATTLE & PORCINE DISEASES

8 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 CATTLE
    • 8.2.1 DAIRY CATTLE
      • 8.2.1.1 Increasing demand for milk & dairy products to boost demand
    • 8.2.2 BEEF CATTLE
      • 8.2.2.1 Increasing demand for beef to drive market
  • 8.3 PORCINE

9 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 CATTLE & PORCINE FARMS
    • 9.2.1 GROWING DEMAND FOR MEAT & DAIRY PRODUCTS TO DRIVE MARKET
  • 9.3 VETERINARY HOSPITALS & CLINICS
    • 9.3.1 INCREASING VETERINARY HEALTHCARE INVESTMENTS IN EMERGING MARKETS TO BOOST DEMAND
  • 9.4 VETERINARY REFERENCE LABORATORIES
    • 9.4.1 INCREASING TECHNOLOGICAL ADVANCEMENTS IN VETERINARY DIAGNOSTICS TO SUPPORT MARKET GROWTH

10 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 10.2.2 US
      • 10.2.2.1 Large-scale livestock operations and advanced veterinary practices to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Rising concerns about food safety & quality to fuel market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Adoption of advanced technologies for milk & dairy products to drive market
    • 10.3.3 UK
      • 10.3.3.1 Favorable government support for animal healthcare to boost demand
    • 10.3.4 FRANCE
      • 10.3.4.1 Growth in veterinary & healthcare industries to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Growing focus on swine & dairy farming to fuel uptake
    • 10.3.6 SWITZERLAND
      • 10.3.6.1 Technologically advanced agriculture sector to fuel market
    • 10.3.7 SPAIN
      • 10.3.7.1 High exports of meat & milk to contribute to market growth
    • 10.3.8 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising focus on dairy industry to drive market
    • 10.4.3 CHINA
      • 10.4.3.1 Rising prevalence of infectious diseases in livestock to propel market
    • 10.4.4 INDIA
      • 10.4.4.1 Expanding cattle population to boost demand
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Emphasis on sustainable & systematic farming practices to support market growth
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Rise in pork & beef consumption to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing demand for veterinary services to fuel uptake
    • 10.5.3 MEXICO
      • 10.5.3.1 Improvements in animal welfare to support market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Growing demand for dairy to fuel market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Product footprint
      • 11.5.5.3 Disease type footprint
      • 11.5.5.4 Animal type footprint
      • 11.5.5.5 End-user footprint
      • 11.5.5.6 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 DYNAMIC COMPANIES
    • 11.6.3 STARTING BLOCKS
    • 11.6.4 RESPONSIVE COMPANIES
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
    • 11.7.1 COMPANY VALUATION
    • 11.7.2 FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 R&D EXPENDITURE OF KEY PLAYERS
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT APPROVALS/LAUNCHES
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS
    • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 ZOETIS INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
        • 12.1.1.3.2 Expansions
        • 12.1.1.3.3 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 MERCK & CO., INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
        • 12.1.2.3.2 Other developments
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 VIRBAC
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
        • 12.1.4.3.2 Expansions
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 ELANCO ANIMAL HEALTH INCORPORATED
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
        • 12.1.5.3.2 Expansions
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Key strengths
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 VETOQUINOL S.A.
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
    • 12.1.7 CEVA SANTE ANIMALE
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 IDEXX LABORATORIES, INC.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Other developments
    • 12.1.9 THERMO FISHER SCIENTIFIC INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 BIOCHEK SMART VETERINARY DIAGNOSTICS
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Expansions
    • 12.1.11 RING BIOTECHNOLOGY CO LTD.
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product launches & approvals
    • 12.1.12 SEQUENT SCIENTIFIC LIMITED
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 HIPRA
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 QIAGEN N.V.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 INNOVATIVE DIAGNOSTICS
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Other developments
  • 12.2 OTHER PLAYERS
    • 12.2.1 COLORADO SERUM COMPANY
    • 12.2.2 INDIAN IMMUNOLOGICALS LTD.
    • 12.2.3 REFIT ANIMAL CARE
    • 12.2.4 CALIER
    • 12.2.5 MEGACOR DIAGNOSTIK GMBH
    • 12.2.6 VETANCO
    • 12.2.7 BIOGENESIS BAGO
    • 12.2.8 ADVACARE PHARMA
    • 12.2.9 BIO-X DIAGNOSTICS S.A.
    • 12.2.10 PAX HEALTHCARE

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Product Code: MD 9200

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: STUDY ASSUMPTION ANALYSIS
  • TABLE 3 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 PAST & PROJECTED TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED AND EMERGING MARKETS (2002-2030)
  • TABLE 5 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • TABLE 7 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: LIST OF MAJOR PATENTS
  • TABLE 13 IMPORT AND EXPORT DATA FOR PRODUCTS RELATED TO CATTLE, PORCINE, REPRODUCTIVE, BY COUNTRY
  • TABLE 14 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
  • TABLE 15 AVERAGE SELLING PRICE OF CATTLE & PORCINE REPRODUCTIVE HEALTH PRODUCTS, BY REGION
  • TABLE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2024-2025)
  • TABLE 17 UNMET NEEDS/END-USER EXPECTATIONS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • TABLE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: IMPACT OF GEN AI
  • TABLE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ROLE IN ECOSYSTEM
  • TABLE 20 CASE STUDY ONE: INNOVATION IN BOVINE REPRODUCTIVE DISEASE VACCINATION BY ZOETIS, INC.
  • TABLE 21 CASE STUDY TWO: TECH-DRIVEN SOLUTIONS FOR LIVESTOCK REPRODUCTIVE HEALTH BY CEVA SANTE ANIMALE (FRANCE)
  • TABLE 22 CASE STUDY THREE: INTEGRATED HEALTH SOLUTIONS FOR CATTLE REPRODUCTIVE HEALTH BY ELANCO ANIMAL HEALTH
  • TABLE 23 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 24 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 ELISA TEST KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 PCR TEST KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 RAPID ANTIGEN TEST KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 OTHER DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 VACCINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 ANTIBIOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 HORMONAL THERAPY MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 OTHER PHARMACEUTICAL PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 37 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 VITAMINS & MINERALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 OTHER SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 41 LEPTOSPIROSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 BRUCELLOSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 BOVINE VIRAL DIARRHEA (BVD) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 VIBRIOSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 OTHER CATTLE & PORCINE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 48 CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 49 CATTLE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 DAIRY CATTLE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 BEEF CATTLE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 54 CATTLE & PORCINE FARMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 VETERINARY HOSPITALS & CLINICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 VETERINARY REFERENCE LABORATORIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 67 US: KEY MACROINDICATORS
  • TABLE 68 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 69 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 73 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 US: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 US: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 76 CANADA: KEY MACROINDICATORS
  • TABLE 77 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 78 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 81 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 CANADA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 CANADA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 85 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 94 GERMANY: KEY MACROINDICATORS
  • TABLE 95 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 96 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 GERMANY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 GERMANY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 103 UK: KEY MACROINDICATORS
  • TABLE 104 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 105 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 UK: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 UK: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 112 FRANCE: KEY MACROINDICATORS
  • TABLE 113 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 114 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 FRANCE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 FRANCE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 121 ITALY: KEY MACROINDICATORS
  • TABLE 122 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 123 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 ITALY: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 ITALY: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 130 SWITZERLAND: KEY MACROINDICATORS
  • TABLE 131 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 132 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 SWITZERLAND: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 SWITZERLAND: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 139 SPAIN: KEY MACROINDICATORS
  • TABLE 140 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 141 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 SPAIN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 SPAIN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 148 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 149 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 REST OF EUROPE: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 REST OF EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 165 JAPAN: KEY MACROINDICATORS
  • TABLE 166 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 167 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 JAPAN: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 JAPAN: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 174 CHINA: KEY MACROINDICATORS
  • TABLE 175 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 176 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 CHINA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 CHINA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 183 INDIA: KEY MACROINDICATORS
  • TABLE 184 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 INDIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 INDIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 192 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 193 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 194 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 AUSTRALIA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 AUSTRALIA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 201 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 202 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 203 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 SOUTH KOREA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 SOUTH KOREA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 REST OF ASIA PACIFIC: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 REST OF ASIA PACIFIC: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 220 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 227 BRAZIL: KEY MACROINDICATORS
  • TABLE 228 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 229 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 BRAZIL: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 BRAZIL: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 236 MEXICO: KEY MACROINDICATORS
  • TABLE 237 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 238 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 MEXICO: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 MEXICO: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 245 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 246 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 250 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 REST OF LATIN AMERICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 REST OF LATIN AMERICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 253 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 255 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 260 MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 GCC COUNTRIES: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 GCC COUNTRIES: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 REST OF MIDDLE EAST & AFRICA: CATTLE REPRODUCTIVE DISEASES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 REST OF MIDDLE EAST & AFRICA: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 278 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • TABLE 279 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DEGREE OF COMPETITION
  • TABLE 280 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PRODUCT FOOTPRINT
  • TABLE 281 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DISEASE TYPE FOOTPRINT
  • TABLE 282 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 283 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: END-USER FOOTPRINT
  • TABLE 284 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: REGION FOOTPRINT
  • TABLE 285 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 286 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 287 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 288 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 289 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 290 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 291 ZOETIS INC.: COMPANY OVERVIEW
  • TABLE 292 ZOETIS INC: PRODUCTS OFFERED
  • TABLE 293 ZOETIS INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 294 ZOETIS INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 295 ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 296 MERCK & CO., INC.: COMPANY OVERVIEW
  • TABLE 297 MERCK & CO., INC.: PRODUCTS OFFERED
  • TABLE 298 MERCK & CO., INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 299 MERCK & CO., INC.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 300 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 301 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 302 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 303 VIRBAC: COMPANY OVERVIEW
  • TABLE 304 VIRBAC: PRODUCTS OFFERED
  • TABLE 305 VIRBAC: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 306 VIRBAC: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 307 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW
  • TABLE 308 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED
  • TABLE 309 ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 310 ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 311 VETOQUINOL S.A.: COMPANY OVERVIEW
  • TABLE 312 VETOQUINOL S.A.: PRODUCTS OFFERED
  • TABLE 313 CEVA SANTE ANIMALE: COMPANY OVERVIEW
  • TABLE 314 CEVA SANTE ANIMALE: PRODUCTS OFFERED
  • TABLE 315 CEVA SANTE ANIMALE: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 316 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 317 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 318 IDEXX LABORATORIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
  • TABLE 319 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 320 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 321 BIOCHEK SMART VETERINARY DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 322 BIOCHEK SMART VETERINARY DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 323 BIOCHEK SMART VETERINARY DIAGNOSTICS: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 324 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
  • TABLE 325 RING BIOTECHNOLOGY CO LTD.: PRODUCTS OFFERED
  • TABLE 326 RING BIOTECHNOLOGY CO LTD.: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 327 SEQUENT SCIENTIFIC LIMITED: COMPANY OVERVIEW
  • TABLE 328 SEQUENT SCIENTIFIC LIMITED: PRODUCTS OFFERED
  • TABLE 329 HIPRA: COMPANY OVERVIEW
  • TABLE 330 HIPRA: PRODUCTS OFFERED
  • TABLE 331 QIAGEN N.V.: COMPANY OVERVIEW
  • TABLE 332 QIAGEN N.V.: PRODUCTS OFFERED
  • TABLE 333 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 334 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 335 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024

List of Figures

  • FIGURE 1 MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
  • FIGURE 8 SUPPLY SIDE ANALYSIS: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2023)
  • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2029)
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR DIAGNOSTICS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR PHARMACEUTICAL PRODUCTS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET FOR SUPPLEMENTS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY DISEASE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 GEOGRAPHIC SNAPSHOT OF CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • FIGURE 21 RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
  • FIGURE 22 PHARMACEUTICALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN GERMANY IN 2023
  • FIGURE 23 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 24 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 25 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 PRODUCTION OF MILK, BY REGION (MILLION METRIC TONS)
  • FIGURE 27 PRODUCTION OF MEAT, BY REGION (MILLION METRIC TONS)
  • FIGURE 28 PRODUCTION OF MEAT, BY ANIMAL TYPE (MILLION METRIC TONS)
  • FIGURE 29 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER (2019-2023)
  • FIGURE 30 NUMBER OF VETERINARIANS IN TOP FIVE EUROPEAN COUNTRIES (2023)
  • FIGURE 31 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
  • FIGURE 33 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 34 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR CATTLE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR CATTLE & PORCINE REPRODUCTIVE DISEASE TREATMENT PATENTS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 39 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 40 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 41 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 42 ADJACENT MARKETS FOR CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET
  • FIGURE 43 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 44 INVESTMENT & FUNDING ACTIVITIES IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2019-2023
  • FIGURE 45 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 46 EUROPE: CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET SNAPSHOT
  • FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2019-2023)
  • FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET (2023)
  • FIGURE 49 RANKING OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2023
  • FIGURE 50 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS0, 2023
  • FIGURE 51 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY FOOTPRINT
  • FIGURE 52 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 YEAR-TO-YEAR (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 56 R&D EXPENDITURE OF KEY PLAYERS IN CATTLE & PORCINE REPRODUCTIVE DISEASES MARKET, 2021-2023
  • FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 MERCK & CO., INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 61 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 62 VETOQUINOL S.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 63 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 64 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 65 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 66 QIAGEN N.V.: COMPANY SNAPSHOT (2023)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!